JP2015505555A5 - - Google Patents

Download PDF

Info

Publication number
JP2015505555A5
JP2015505555A5 JP2014555310A JP2014555310A JP2015505555A5 JP 2015505555 A5 JP2015505555 A5 JP 2015505555A5 JP 2014555310 A JP2014555310 A JP 2014555310A JP 2014555310 A JP2014555310 A JP 2014555310A JP 2015505555 A5 JP2015505555 A5 JP 2015505555A5
Authority
JP
Japan
Prior art keywords
inhibition
cancer
compound
protein kinase
autoimmune disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014555310A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015505555A (ja
JP6199316B2 (ja
Filing date
Publication date
Priority claimed from GBGB1201566.5A external-priority patent/GB201201566D0/en
Application filed filed Critical
Publication of JP2015505555A publication Critical patent/JP2015505555A/ja
Publication of JP2015505555A5 publication Critical patent/JP2015505555A5/ja
Application granted granted Critical
Publication of JP6199316B2 publication Critical patent/JP6199316B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014555310A 2012-01-30 2013-01-30 1H−ピロロ[2,3−b]ピリジン誘導体およびキナーゼ阻害剤としてのその使用 Expired - Fee Related JP6199316B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1201566.5A GB201201566D0 (en) 2012-01-30 2012-01-30 New chemical compounds
GB1201566.5 2012-01-30
PCT/GB2013/050212 WO2013114113A1 (en) 2012-01-30 2013-01-30 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2015505555A JP2015505555A (ja) 2015-02-23
JP2015505555A5 true JP2015505555A5 (cg-RX-API-DMAC7.html) 2015-11-12
JP6199316B2 JP6199316B2 (ja) 2017-09-20

Family

ID=45876325

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014555310A Expired - Fee Related JP6199316B2 (ja) 2012-01-30 2013-01-30 1H−ピロロ[2,3−b]ピリジン誘導体およびキナーゼ阻害剤としてのその使用

Country Status (21)

Country Link
US (3) US10000481B2 (cg-RX-API-DMAC7.html)
EP (1) EP2809670B1 (cg-RX-API-DMAC7.html)
JP (1) JP6199316B2 (cg-RX-API-DMAC7.html)
CN (4) CN104203948A (cg-RX-API-DMAC7.html)
AU (1) AU2013213954B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014018795B1 (cg-RX-API-DMAC7.html)
CA (1) CA2862940C (cg-RX-API-DMAC7.html)
DK (1) DK2809670T3 (cg-RX-API-DMAC7.html)
EA (1) EA026657B1 (cg-RX-API-DMAC7.html)
ES (1) ES2637340T3 (cg-RX-API-DMAC7.html)
GB (1) GB201201566D0 (cg-RX-API-DMAC7.html)
HK (1) HK1200447A1 (cg-RX-API-DMAC7.html)
HU (1) HUE035332T2 (cg-RX-API-DMAC7.html)
IL (1) IL233595B (cg-RX-API-DMAC7.html)
IN (1) IN2014DN06104A (cg-RX-API-DMAC7.html)
MX (1) MX352927B (cg-RX-API-DMAC7.html)
NZ (1) NZ627361A (cg-RX-API-DMAC7.html)
PL (1) PL2809670T3 (cg-RX-API-DMAC7.html)
PT (1) PT2809670T (cg-RX-API-DMAC7.html)
WO (1) WO2013114113A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201405070B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201201566D0 (en) 2012-01-30 2012-03-14 Vernalis R&D Ltd New chemical compounds
KR102096679B1 (ko) * 2012-04-23 2020-04-02 제넨테크, 인크. 화합물의 제조를 위한 중간체 및 방법
JP6463758B2 (ja) * 2013-08-22 2019-02-06 ジェネンテック, インコーポレイテッド 化合物の調製方法
CN104829609B (zh) * 2014-02-11 2016-08-03 北大方正集团有限公司 取代的吡啶并嘧啶化合物及其制备方法和应用
MA41559A (fr) 2015-09-08 2017-12-26 Taiho Pharmaceutical Co Ltd Composé de pyrimidine condensé ou un sel de celui-ci
US10032914B2 (en) * 2015-10-20 2018-07-24 Taiwan Semiconductor Manufacturing Co., Ltd. Semiconductor device and manufacturing method thereof
EP3269370B1 (en) 2016-02-23 2020-01-08 Taiho Pharmaceutical Co., Ltd. Novel condensed pyrimidine compound or salt thereof
EP3674325A4 (en) 2017-08-21 2021-11-03 Taiho Pharmaceutical Co., Ltd. FUSION PROTEIN OF DCTN1 PROTEIN WITH RET PROTEIN
TW202043198A (zh) 2019-01-17 2020-12-01 美商Ifm Due有限公司 用於治療與sting活性相關之病況的化合物及組合物
CN111518096B (zh) 2019-02-02 2022-02-11 江苏威凯尔医药科技有限公司 两面神激酶jak家族抑制剂及其制备和应用
WO2021019514A1 (en) 2019-08-01 2021-02-04 Integral Biosciences Pvt. Ltd. Heterocyclic compounds as kinase inhibitor and uses thereof
IT202000005527A1 (it) * 2020-03-16 2021-09-16 Univ Degli Studi Di Trento Trattamento terapeutico di cromatinopatie
TW202216685A (zh) * 2020-07-15 2022-05-01 美商Ifm Due有限公司 用於治療與sting活性相關的病狀之化合物及組合物
EP4182310A1 (en) 2020-07-15 2023-05-24 IFM Due, Inc. Compounds and compositions for treating conditions associated with sting activity
EP4182030A1 (en) * 2020-07-15 2023-05-24 IFM Due, Inc. Compounds and compositions for treating conditions associated with sting activity
JP2024502474A (ja) 2021-01-08 2024-01-19 アイエフエム デュー インコーポレイテッド Sting活性に関連する状態を治療するための、尿素を有するヘテロ二環式化合物または類似体およびその組成物
US20230250060A1 (en) * 2022-01-12 2023-08-10 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
CN116554170A (zh) * 2023-04-26 2023-08-08 上海大学 4-氟-7-氮杂吲哚的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1012976A (en) * 1909-03-25 1911-12-26 Adolf Bordt Adding-machine.
WO2003028724A1 (en) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
US7531553B2 (en) * 2003-03-21 2009-05-12 Amgen Inc. Heterocyclic compounds and methods of use
PH12012501891A1 (en) * 2003-11-21 2013-09-02 Array Biopharma Inc Akt protein kinase inhibitors
CN101959887B (zh) * 2008-01-08 2013-07-31 阵列生物制药公司 作为激酶抑制剂的吡咯并吡啶
CA2712959C (en) * 2008-01-22 2015-06-23 Vernalis (R & D) Ltd Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity
CL2009001152A1 (es) * 2008-05-13 2009-10-16 Array Biopharma Inc Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
ES2392489T3 (es) * 2008-06-11 2012-12-11 Genentech, Inc. Dicarbazoles y procedimientos de uso
WO2011017142A1 (en) * 2009-08-06 2011-02-10 Merck Patent Gmbh Novel bicyclic urea compounds
EP2571361A4 (en) * 2010-05-19 2013-11-13 Univ North Carolina PYRAZOLOPYRIMIDINE COMPOUNDS FOR CANCER TREATMENT
GB201201566D0 (en) * 2012-01-30 2012-03-14 Vernalis R&D Ltd New chemical compounds

Similar Documents

Publication Publication Date Title
JP2015505555A5 (cg-RX-API-DMAC7.html)
IL263955B (en) Registration maps using intra-cardiac signals
IL244748B (en) Methods and processes for non-invasive assessment of genetic variations
JP2015125255A5 (cg-RX-API-DMAC7.html)
JP2017537928A5 (cg-RX-API-DMAC7.html)
EP2951139A4 (en) SYNTHESIS FROM 1,1,2,3-TETRACHLORPROPENE
JP2015503422A5 (cg-RX-API-DMAC7.html)
HUE050905T4 (hu) Galektin-9 ellen irányuló antitest, amely a regulátor T-limfociták szuppresszor-aktivitásának gátlója
HUE056006T2 (hu) Kombináció Parkinson-kór kezelésére
FI20155015A7 (fi) Kapasitiivisen sensorin jatkuva itsetestaus
HUE043206T2 (hu) Kortisztatin-analógok gyulladásos és/vagy immunbetegségek kezelésére
EP2971207A4 (en) PREPARATION OF ALUMINUM SCANDIUM ALLOYS
EP3571751A4 (en) CENTRAL / DISTRIBUTED OPTIMIZER ARCHITECTURE
PL3487491T3 (pl) Kompozycje do zwiększenia aktywności mózgu
EP3506254A4 (en) SOUNDPROOF STRUCTURE
IL252886A0 (en) Processes and systems for catalytic manufacture of wax ester derivatives
PL3226888T3 (pl) Podawanie selektywnego transsygnałowego inhibitora IL-6
EP2999472A4 (en) AURORA KINASE INHIBITORS
WO2015066485A3 (en) Mitochondrial disease genetic diagnostics
ES1117305Y (es) Despertador para activar la incorporación del usuario.
MacKay The engine of memory
JP2017516883A5 (cg-RX-API-DMAC7.html)
DK2929880T3 (da) Terapeutisk middel til sygdom baseret på hæmmende effekt af makrofag-migrationshæmmende faktor
ELIZABETH New Histories of Slaves and Freed
FR3004992B1 (fr) Roulette pour meuble ou analogue avec moyens de blocage